The truth about being a GP
We asked GPs across the UK to share their learning experiences through our reflective writing compet... Read more
News
Online tool offers hereditary cancer risk assessment
28-Apr-08
Patients worried about their risk of hereditary cancer can now get a personal assessment through an online tool by Macmillan Cancer Support.
Nine out of 10 people with a family history of cancer are thought to overestimate their risk, according to a poll last year. It also showed that 60 per cent of people wrongly believe that cancer is the biggest risk factor for cancer.
But an online programme called Online Personal Education and Risk Assessment (OPERA) could help allay fears over risk of inherited breast and ovarian cancer.
Users are asked to answer a few simple questions about themselves and their families, from which OPERA produces personalised information and advice.
DoH cancer czar Profesor Mike Richards said: ‘For many it will provide reassurance that the risk is not as high as they feared. For others it will provide the information which prompts them to see their GP.'
Comment below and tell us what you think
Tools
Healthcare Republic Forums
Hottest Topics
Registrar
Assessment guide is useful for all
Mock scenarios and helpful exercises make this book more than an exam guide, says Dr Lizzie Croton. Read more
Women's health - Terminate pregnancies
Requests for pregnancy termination should be handled with sensitivity, writes Dr Mona Kular. Read more
Latest Clinical Articles
Sjogren's syndrome
Contributed by Dr Jeffery Lee, consultant rheumatologist, Barnet Hospital, Hertfordshire. Read more
Chronic kidney disease
Section 1: Epidemiology and classification Chronic kidney disease (CKD) encompasses abnor... Read more
Acute kidney injury
Contributed by Dr Stephan Brincat, specialist registrar, and Dr Rachel Hilton, consultant nephrologi... Read more
MIMS Product News
New drug - Eucreas
Eucreas (vildagliptin + metformin) is a new fixed-dose combination treatment for patients inadequate... Read more
New drug - Galvus
Novartis has launched a new oral hypoglycaemic for the treatment type II diabetes. Read more
Coversyl formulation change
Coversyl and Coversyl Plus have been discontinued and replaced by Coversyl Arginine and Coversyl Arg... Read more
Jobs
Job of the Week
- Salaried GP North West England
- Maternity Locum GP South East England
- GPs wanted for New Zealand Other International
- GP North West England
- Salaried GP East Midlands
- Partner South East England
- Replacement Full Time Partner and Full Time Salaried Doctor North West England
- Locum GPs wanted North East England
- Salaried GP East of England
- Partnership North West England
Comments
Rupen Kulkarni
28/04/2008
Looks useful. Hope it is reliable and patients can get facts rather than more things to worry about.
Only registered users may comment. Log in now or register for a free account.